Dihydroxyphenylisoindoline Amides as Orally Bioavailable Inhibitors of the Heat Shock Protein 90 (Hsp90) Molecular Chaperone
摘要:
The discovery and optimization of potency and metabolic stability of a novel class of dihyroxyphenylisoindoline amides as Hsp90 inhibitors are presented. Optimization of a screening hit using structure-based design and modification of log D and chemical structural features led to the identification of a class of orally bioavailable non-quinone-containing Hsp90 inhibitors. This class is exemplified by 14 and 15, which possess improved cell potency and pharmacokinetic profiles compared with the original screening hit.
[EN] 2-AMINO PYRIMIDINE COMPOUNDS AS POTENT HSP-90 INHIBITORS<br/>[FR] COMPOSÉS 2-AMINO PYRIMIDINE COMME INHIBITEURS PUISSANTS DE L'HSP-90
申请人:PFIZER
公开号:WO2010018481A1
公开(公告)日:2010-02-18
The present invention is directed to compounds of Formula (I), or pharmaceutically acceptable salts thereof, their synthesis, and their use as HSP-90 inhibitors in the treatment of proliferative diseases, e.g. cancer.
The present invention is directed to compounds of formula (I), and pharmaceutically acceptable salts thereof, their synthesis, and their use as HSP-90 inhibitors.
2-amino pyrimidine compounds as potent HSP-90 inhibitors
申请人:Pfizer Inc.
公开号:US08080556B2
公开(公告)日:2011-12-20
The present invention is directed to compounds of formula (I),
or pharmaceutically acceptable salts thereof, their synthesis, and their use as HSP-90 inhibitors.
The present invention is directed to compounds of formula (I),
and pharmaceutically acceptable salts and solvates thereof, their synthesis, and their use as HSP-90 inhibitors.